Development and Management of Registry in Patients With Gynecologic Cancer in Korea
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patient registry.
- Who it may be relevant to
- Registry conditions: Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Fallopian Tube Cancer. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.
Detailed description
Cervical cancer, endometrial cancer, and ovarian cancer represent gynecologic cancers. There are many open issues that need to be addressed, specifically the surgical method, disease recurrence and survival outcome in the so called "real world" setting. The aim of this observational study is to collect both retrospective and prospective medical information of gynecologic cancer patients.
Interventions
- Other Patient registry
Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Primary outcome measures
- Overall survival [Time frame: 5 years]
Secondary outcome measures (1)
- Progression-free survival [Time frame: 5 years]
Eligibility criteria
Inclusion criteria
- Female patients 18 years or older
- Written informed consent (prospective cohort)
- Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Exclusion criteria
- Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
South Korea · 1 center
- Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Med — Seoul
Identifiers
NCT: NCT05912972 · 2022-1412